Literature DB >> 3197284

Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states.

J S Cohn1, J R McNamara, E J Schaefer.   

Abstract

Lipoprotein cholesterol concentrations in plasma are routinely estimated by using the Friedewald formula, whereby very-low-density lipoprotein cholesterol (VLDL-C) is estimated to be one-fifth the plasma triglyceride concentration. Ordinarily, this formula is applied only to plasma sampled from patients in the fasted state. To determine whether lipoprotein cholesterol measurements are altered substantially in plasma sampled from nonfasting subjects, we obtained postprandial blood samples from 22 healthy subjects (nine men, 13 women, ages 22-79 years) fed a fat-rich meal (1 g fat per kilogram body wt.). The plasma triglyceride concentration increased postprandially in all subjects (233 +/- 16% of baseline at 3 h). The mean cholesterol concentration in plasma was essentially unchanged. High-density lipoprotein cholesterol (HDL-C) was significantly decreased (94 +/- 2% at 3 h, P less than 0.001). VLDL-C and low-density lipoprotein cholesterol (LDL-C), estimated by the Friedewald formula, were compared with measurements obtained by modified Lipid Research Clinics (LRC) methodology. As measured by either method, VLDL-C increased and LDL-C decreased significantly after the fat-rich meal. These postprandial changes were significantly greater (P less than 0.01) when estimated by the Friedewald formula than by LRC methodology. We conclude that (a) lipoprotein cholesterol concentrations measured in the fed subject differ significantly from those measured in the fasted subject, and (b) plasma must be obtained after at least a 12-h fast if an individual's risk of coronary heart disease is to be accurately assessed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197284

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism.

Authors:  Nedret Tanaci; Derun Taner Ertugrul; Mustafa Sahin; Muammer Yucel; Irem Olcay; Nilgun Guvener Demirag; Alptekin Gursoy
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia; T B Ledue; W Y Craig
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

3.  Usefulness of the Martin Method for Estimation of Low-Density Lipoprotein Cholesterol in Coronary Atherosclerosis.

Authors:  Soie Chung
Journal:  Med Princ Pract       Date:  2017-12-04       Impact factor: 1.927

4.  Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population.

Authors:  Hendrick E van Deventer; W Greg Miller; Gary L Myers; Ikunosuke Sakurabayashi; Lorin M Bachmann; Samuel P Caudill; Andrzej Dziekonski; Selvin Edwards; Mary M Kimberly; William J Korzun; Elizabeth T Leary; Katsuyuki Nakajima; Masakazu Nakamura; Robert D Shamburek; George W Vetrovec; G Russell Warnick; Alan T Remaley
Journal:  Clin Chem       Date:  2011-01-12       Impact factor: 8.327

Review 5.  Fasting or Non-fasting Lipids for Atherosclerotic Cardiovascular Disease Risk Assessment and Treatment?

Authors:  Faisal Rahman; Roger S Blumenthal; Steven R Jones; Seth S Martin; Tyler J Gluckman; Seamus P Whelton
Journal:  Curr Atheroscler Rep       Date:  2018-02-17       Impact factor: 5.113

6.  The Royal Marsden Hospital pilot tamoxifen chemoprevention trial.

Authors:  T J Powles; A L Jones; S E Ashley; M E O'Brien; V A Tidy; J Treleavan; D Cosgrove; A G Nash; N Sacks; M Baum
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.

Authors:  Samia Mora; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2008-08-18       Impact factor: 29.690

8.  Optimism and Lipid Profiles in Midlife: A 15-Year Study of Black and White Adults.

Authors:  Farah Qureshi; Jackie Soo; Ying Chen; Brita Roy; Donald M Lloyd-Jones; Laura D Kubzansky; Julia K Boehm
Journal:  Am J Prev Med       Date:  2022-01-20       Impact factor: 5.043

9.  Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

Authors:  Børge G Nordestgaard; Anne Langsted; Samia Mora; Genovefa Kolovou; Hannsjörg Baum; Eric Bruckert; Gerald F Watts; Grazyna Sypniewska; Olov Wiklund; Jan Borén; M John Chapman; Christa Cobbaert; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Kari Pulkki; Florian Kronenberg; Alan T Remaley; Nader Rifai; Emilio Ros; Michel Langlois
Journal:  Eur Heart J       Date:  2016-04-26       Impact factor: 29.983

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.